Tambi Brian
Director at Insys Therapeutics, Inc.; Director at AKORN INC
- Sold, on record
- $3.7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest May 10, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Insys Therapeutics, Inc.Director
- AKORN INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Insys Therapeutics, Inc.176,504 shares
- AKORN INC60,265 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AKORN INCUnusualSep 12, 2014 2014
Sold 13,800 shares at $38.00 ($524k)
Tambi Brian, Director
Sold 28.4% of holdings ($1.8M position)34,791 shares leftFirst sale on recordFiling
- 2 Form 4 sale AKORN INCPlan not statedDec 15, 2014 +94 days
Sold 1,200 shares at $41.86 ($50k)
Tambi Brian, Director
Sold 3.4% of holdings ($1.5M position)33,591 shares leftFiling
- 3 Form 4 sale Insys Therapeutics, Inc.UnusualMay 20, 2015 +156 days
Sold 5,100 shares at $60.11 ($307k)
Tambi Brian, Director
Sold 100% of holdings ($307k position)0 shares leftFirst sale on recordFiling
- 4 Form 4 sale Insys Therapeutics, Inc.UnusualMay 27, 2015 +7 days
Sold 4,900 shares at $60.06 ($294k)
Tambi Brian, Director
Sold 100% of holdings ($294k position)0 shares leftFiling
- 5 Form 4 sale AKORN INCUnusualJun 2, 2016 +372 days
Sold 25,000 shares at $30.73 ($768k)
Tambi Brian, Director
Sold 29.9% of holdings ($2.6M position)58,591 shares leftFiling
- 6 Form 4 sale AKORN INCPlan not statedAug 4, 2017 +428 days
Sold 5,165 shares at $33.37 ($172k)
Tambi Brian, Director
Sold 7.2% of holdings ($2.4M position)66,175 shares leftFiling
- 7 Form 4 sale AKORN INCPlan not statedNov 21, 2017 +109 days
Sold 15,100 shares at $33.35 ($504k)
Tambi Brian, Director
Sold 22.8% of holdings ($2.2M position)51,075 shares leftFiling
- 8 Form 4 sale Insys Therapeutics, Inc.UnusualMay 10, 2018 +170 days
Sold 166,504 shares at $6.41 ($1.1M)
Tambi Brian, Director
Sold 100% of holdings ($1.1M position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2018 | May 14, 2018 | Insys Therapeutics, Inc. | Director | Form 4 sale | 166,504 | $1.1M | 100.0% | Unusual | SEC |
| Nov 21, 2017 | Nov 22, 2017 | AKORN INC | Director | Form 4 sale | 15,100 | $504k | 22.8% | Plan not stated | SEC |
| Aug 4, 2017 | Aug 9, 2017 | AKORN INC | Director | Form 4 sale | 5,165 | $172k | 7.2% | Plan not stated | SEC |
| Jun 2, 2016 | Jun 6, 2016 | AKORN INC | Director | Form 4 sale | 25,000 | $768k | 29.9% | Unusual | SEC |
| May 27, 2015 | May 27, 2015 | Insys Therapeutics, Inc. | Director | Form 4 sale | 4,900 | $294k | 100.0% | Unusual | SEC |
| May 20, 2015 | May 20, 2015 | Insys Therapeutics, Inc. | Director | Form 4 sale | 5,100 | $307k | 100.0% | Unusual | SEC |
| Dec 15, 2014 | Dec 16, 2014 | AKORN INC | Director | Form 4 sale | 1,200 | $50k | 3.4% | Plan not stated | SEC |
| Sep 12, 2014 | Sep 15, 2014 | AKORN INC | Director | Form 4 sale | 13,800 | $524k | 28.4% | Unusual | SEC |